Rocket Lab (RKLB) is trading down at $45.42 (-10.92%) on NASDAQ, as of the latest quote. It is a Nasdaq-100 constituent in the Industrials sector.
What the tracked firms say
8 open price targets on Rocket Lab from 6 firms, as of Nov 12, 2026 (the newest target counted).
1 firm stated no rating.
Counted from the targets listed below: each firm once, at its latest open target. Ratings are the firms' own words, grouped only where the word is unambiguous. This is a summary of what the firms published, not a forecast or advice from Dalsna Finance, and it is not a consensus estimate. How we collect and score targets.
8 targets, newest first. Open a row for its source and scoring.
Entry price $64.1, the close nearest Nov 12, 2026, when the target was reported; the target is +33% from it.
Horizon No horizon stated, so it is tracked over the 12-month default, to Nov 2027.
Scoring Open: judged on the close on Nov 12, 2027.
Berenberg analyst Michael Filatov raised his price target on Rocket Lab ($RKLB) stock to $85 from $83
Entry price $66.5, the close nearest Nov 11, 2026, when the target was reported; the target is +67% from it.
Horizon No horizon stated, so it is tracked over the 12-month default, to Nov 2027.
Scoring Open: judged on the close on Nov 11, 2027.
dropped their target price on shares of Rocket Lab from $122.00 to $111.00
Entry price $66.5, the close nearest Nov 11, 2026, when the target was reported; the target is +50% from it.
Horizon No horizon stated, so it is tracked over the 12-month default, to Nov 2027.
Scoring Open: judged on the close on Nov 11, 2027.
had its target price dropped by Needham & Company LLC from $120.00 to $100.00
Entry price $60.1, the close nearest Nov 10, 2026, when the target was reported; the target is +36% from it.
Horizon No horizon stated, so it is tracked over the 12-month default, to Nov 2027.
Scoring Open: judged on the close on Nov 10, 2027.
RKLB Maintained by Barclays -- Price Target Lowered to $82
Entry price $55.3, the close nearest Oct 16, 2026, when the target was reported; the target is +117% from it.
Horizon No horizon stated, so it is tracked over the 12-month default, to Oct 2027.
Scoring Open: judged on the close on Oct 16, 2027.
Investing.com - Needham maintained its Buy rating and $120 price target on Rocket Lab USA stock (NASDAQ:RKLB) following a delay in the company’s Neutron rocket program.
Entry price $55.3, the close nearest Oct 16, 2026, when the target was reported; the target is +63% from it.
Horizon No horizon stated, so it is tracked over the 12-month default, to Oct 2027.
Scoring Open: judged on the close on Oct 16, 2027.
Citizens lowered its price target on Rocket Lab USA (NASDAQ:RKLB) to $90 from $130.
Entry price $52.9, the close nearest Oct 15, 2026, when the target was reported; the target is +89% from it.
Horizon No horizon stated, so it is tracked over the 12-month default, to Oct 2027.
Scoring Open: judged on the close on Oct 15, 2027.
KeyBanc lowered its price target on Rocket Lab USA (NASDAQ:RKLB) shares to $100 from $135 while maintaining an Overweight rating on the stock.
KeyBanc Capital Markets’s track record → Link to this target
Entry price $52.9, the close nearest Oct 15, 2026, when the target was reported; the target is +131% from it.
Horizon No horizon stated, so it is tracked over the 12-month default, to Oct 2027.
Scoring Open: judged on the close on Oct 15, 2027.
Cantor Fitzgerald reiterated an Overweight stock rating and $122.00 price target on Rocket Lab USA
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
6 firms have a price target on Rocket Lab tracked here, newest first. Each links to that firm's full record.
| FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $35.2M | $62.2M | $211.0M | $244.6M | $436.2M | $601.8M |
| Growth (year over year) | — | +77.0% | +239.0% | +15.9% | +78.3% | +38.0% |
| Gross profit | −$11.8M | −$1.89M | $19.0M | $51.4M | $116.1M | $207.2M |
| Gross margin | −33.6% | −3.0% | 9.0% | 21.0% | 26.6% | 34.4% |
| Operating income | −$55.0M | −$102.1M | −$135.2M | −$177.9M | −$189.8M | −$228.8M |
| Operating margin | −156.3% | −164.0% | −64.1% | −72.7% | −43.5% | −38.0% |
| Net income | −$55.0M | −$117.3M | −$135.9M | −$182.6M | −$190.2M | −$198.2M |
| Net margin | −156.4% | −188.5% | −64.4% | −74.6% | −43.6% | −32.9% |
| EPS (diluted) | −$0.73 | −$0.56 | −$0.29 | −$0.38 | −$0.38 | −$0.37 |
| Balance sheet | ||||||
| Cash and equivalents | $52.8M | $691.0M | $242.5M | $162.5M | $271.0M | $828.7M |
| Total assets | $187.9M | $980.8M | $989.1M | $941.2M | $1.18B | $2.32B |
| Total liabilities | $79.6M | $282.4M | $315.9M | $386.7M | $801.9M | $602.6M |
| Long-term debt | $0 | $97.3M | $100.0M | $87.6M | $44.0M | $1.72M |
| Shareholders' equity | −$166.7M | $698.4M | $673.2M | $554.5M | $382.5M | $1.72B |
| Cash flow | ||||||
| Operating cash flow | −$27.8M | −$71.8M | −$106.5M | −$98.9M | −$48.9M | −$165.5M |
| Capital expenditure | $25.1M | $25.7M | $42.4M | $54.7M | $67.1M | $156.3M |
| Free cash flow | −$52.9M | −$97.5M | −$148.9M | −$153.6M | −$116.0M | −$321.8M |
| Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | Q3 FY26Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $132.4M | $122.6M | $144.5M | $155.1M | $179.7M | $200.3M | $234.1M | $267.8M |
| Growth (year over year) | +120.7% | +32.1% | +36.0% | +48.0% | +35.7% | +63.5% | +62.0% | +72.7% |
| Gross profit | $36.8M | $35.2M | $46.4M | $57.3M | $68.2M | $76.5M | $84.6M | $90.1M |
| Gross margin | 27.8% | 28.8% | 32.1% | 37.0% | 38.0% | 38.2% | 36.1% | 33.6% |
| Operating income | −$51.5M | −$59.2M | −$59.6M | −$59.0M | −$51.0M | −$56.0M | −$57.5M | −$79.2M |
| Operating margin | −38.9% | −48.3% | −41.3% | −38.0% | −28.4% | −27.9% | −24.6% | −29.6% |
| Net income | −$52.3M | −$60.6M | −$66.4M | −$18.3M | −$52.9M | −$45.0M | −$49.3M | −$79.7M |
| Net margin | −39.5% | −49.5% | −46.0% | −11.8% | −29.5% | −22.5% | −21.0% | −29.7% |
| EPS (diluted) | −$0.10 | −$0.12 | −$0.13 | −$0.03 | −$0.09 | −$0.07 | −$0.08 | −$0.12 |
| Balance sheet | ||||||||
| Cash and equivalents | $271.0M | $303.1M | $564.1M | $807.9M | $828.7M | $1.21B | $2.13B | $4.45B |
| Total assets | $1.18B | $1.25B | $1.55B | $2.22B | $2.32B | $2.82B | $4.19B | $6.57B |
| Total liabilities | $801.9M | $823.7M | $864.7M | $940.4M | $602.6M | $555.6M | $695.2M | $766.1M |
| Long-term debt | $44.0M | $57.7M | $53.7M | $51.3M | $1.72M | $1.72M | $1.72M | $1.72M |
| Shareholders' equity | $382.5M | $431.3M | $688.5M | $1.28B | $1.72B | $2.26B | $3.49B | $5.80B |
| Cash flow | ||||||||
| Operating cash flow | −$2.39M | −$54.2M | −$23.2M | −$23.5M | −$64.5M | −$50.3M | −$84.1M | $7.15M |
| Capital expenditure | $21.6M | $28.7M | $32.0M | $45.9M | $49.7M | $27.1M | $26.0M | $31.1M |
| Free cash flow | −$23.9M | −$82.9M | −$55.3M | −$69.4M | −$114.2M | −$77.4M | −$110.1M | −$23.9M |
From Rocket Lab's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
The last 8 quarters as Rocket Lab (RKLB) reported them to the SEC: revenue and diluted earnings per share under GAAP, as filed (a figure marked * is our calculation, not a filed one). No estimates. The change columns are our calculation from these figures.
| Fiscal quarter | Reported | Revenue | vs prior quarter (our calculation) | vs a year earlier (our calculation) | Diluted EPS | vs prior quarter (our calculation) | vs a year earlier (our calculation) | Filings |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026Jul–Sep 2026 | Nov 9, 2026 | $267.8M | +14.4% | +72.7% | −$0.12 | n/a | n/a | 8-K results · 10-Q |
| Q2 FY2026Apr–Jun 2026 | Aug 10, 2026 | $234.1M | +16.8% | +62.0% | −$0.08 | n/a | n/a | 8-K results · 10-Q |
| Q1 FY2026Jan–Mar 2026 | May 7, 2026 | $200.3M | +11.5% | +63.5% | −$0.07 | n/a | n/a | 8-K results · 10-Q |
| Q4 FY2025Oct–Dec 2025 | Feb 26, 2026 | $179.7M* | +15.8% | +35.7% | —† | n/a | n/a | 8-K results · 10-K |
| Q3 FY2025Jul–Sep 2025 | Nov 10, 2025 | $155.1M | +7.3% | +48.0% | −$0.03 | n/a | n/a | 8-K results · 10-Q |
| Q2 FY2025Apr–Jun 2025 | Aug 7, 2025 | $144.5M | +17.9% | +36.0% | −$0.13 | n/a | n/a | 8-K results · 10-Q |
| Q1 FY2025Jan–Mar 2025 | May 8, 2025 | $122.6M | −7.4% | +32.1% | −$0.12 | n/a | n/a | 8-K results · 10-Q |
| Q4 FY2024Oct–Dec 2024 | Feb 27, 2025 | $132.4M* | +26.3% | +120.7% | —† | n/a | n/a | 8-K results · 10-K |
"Reported" is the day the results release (an 8-K under Item 2.02) was accepted by the SEC; where we have none on file it is the day the quarterly or annual report was filed, and says which. * Our calculation: revenue for a fourth quarter the company reports only within its full year, worked out as the 10-K's year less the first three quarters. † Not shown: the company reports this quarter's diluted EPS only within its full year, and per-share amounts do not add up across quarters (the share count changes), so the year less nine months would differ from the company's own fourth-quarter figure. Changes against it are left blank too. n/a: no comparable quarter, or a zero or negative base, where a percentage would mislead. Source: the company's filings on SEC EDGAR.
Read at Yahoo Finance ↗ Link to this story
Also mentions SpaceX, AST SpaceMobile
Rocket Lab Corporation is a publicly traded aerospace manufacturer and launch service provider. Its Electron orbital rocket launches small satellites and has successfully completed over 75 missions as of January 2026, making it the most prolific small-lift launch vehicle in operation globally. A suborbital variant of Electron, called HASTE, was developed as a testbed to advance hypersonic technology development, while the next-generation reusable Neutron medium-lift launch vehicle is in development to support constellation deployment, interplanetary missions, and human spaceflight. The company is a supplier of satellite components such as star trackers, reaction wheels, solar panels, electric propulsion systems, software-defined radios, composite structures, separation systems, and electro-optical and infrared (EO/IR) sensors, as well as flight and ground software. The company also manufactures satellite buses and complete spacecraft as part of its strategic vision to become a vertically integrated, end-to-end space company.
Source: Wikipedia — Rocket Lab
No public reader scorecards on Rocket Lab yet. Set a price target with a date and it is scored in public.
Make your own scorecardHow federal capital gains are taxed (general information, not tax advice)